Transdermal estradiol patches may be an alternative to LHRHas when combined with ARPIs to treat mHSPC, researchers say.

Responses were similar among patients with estrogen patches and ARPIs compared to luteinizing hormone releasing hormone ...

Other key areas will be microneedle vaccines and transdermal patches for management of chronic disease. The two-day agenda offers you peer-to-peer networking with CEO’s, Senior Vice presidents ...

Am J Health Syst Pharm. 2012;69(2):116-124. For this article, information on about three dozen currently available TDDS products commonly encountered in clinical practice was compiled through a ...

Expert Rev Neurother. 2012;12(11):1351-1365. With regard to understanding the disease process in AD, it is of considerable interest to consider the temporal relationship between the loss of ...